On a cloudy early morning in Afghanistan’s Laghman province, Dr Arsala set out for Alingar—a rugged, mountain-wrapped district he had visited many times before. After 12 years as a Provincial Polio Officer, he knew the rhythm of polio campaigns: the early starts, the long drives, the predictable challenges. But this
Read more
Kabul, 30 August 2025 – The Ministry of Public Health of Islamic Emirate of Afghanistan has launched a combined fractional Inactivated Polio Vaccine (fIPV) and Oral Polio Vaccine (OPV) campaign in the eastern region of the country, covering Nangarhar, Kunar, Laghman, and Nuristan provinces.
Read more
PharmaJet has secured a contract to facilitate the inaugural major deployment of an intradermal polio vaccination initiative in Afghanistan, utilizing its Tropis needle-free delivery mechanism. This development is an extension of the system's prior application in analogous public health endeavors across Pakistan, Nigeria, and Somalia.
Read more
Egypt is set to explore the use of needle-free injections for polio immunisation, following a new agreement between US-based medical technology firm PharmaJet, local manufacturer EVA Pharma, and the Egyptian Unified Procurement Authority (UPA).
Read more
Immuno Cure BioTech, a clinical-stage biotechnology startup based in Hong Kong Science Park, has announced its upcoming collaboration with PharmaJet® to evaluate the safety and immunogenicity of HIV therapeutic DNA vaccine, ICVAX, delivered via PharmaJet's innovative Tropis® needle-free injection system in a clinical study.
Read more
A recent study published in Vaccines explores the impact of needle-free delivery of fractional dose inactivated polio vaccine (fIPV) on Nigeria’s routine immunization program. The research assesses the feasibility, cost-effectiveness, and impact of using a WHO-prequalified, intradermal needle-free device, Tropis®, for fIPV administration.
Read more
A study in Nigeria has found that needle-free, intradermal delivery of the inactivated polio vaccine (IPV) has the potential to significantly improve vaccination coverage and reduce costs in routine immunization programs. The findings offer a promising path forward for strengthening polio eradication efforts and expanding access to immunization in resource-limited
Read more
(Vax-Before-Travel News) As the world is confronted with an increasing number of countries reporting polio cases and poliovirus detections, an innovative vaccination strategy has been launched in polio hot spots.
Read more
PharmaJet’s Tropis ID needle-free delivery system for fractional IPV (fIPV) administration increased second-dose IPV coverage by 11% compared to full-dose intramuscular administration, according to results from a Nigeria-based implementation study.
Read more
The Drugs Controller General of India (DCGI) has granted Emergency Use Authorisation (EUA) to India's first mRNA-based Omicron booster vaccine, and it is likely to be rolled out in 2-3 weeks, Gennova Biopharmaceuticals announced on Tuesday.
Read more
The Pune-based firm's GemCovac-OM is a monovalent needle-free booster shot. It will be delivered intradermally with the PharmaJet Tropis Precision Delivery System (PDS) to adults of 18 years of age and older
Read more
Gennova Biopharmaceuticals has applied for an emergency use authorisation (EUA) from the Drug Controller General of India (DCGI) for its mRNA-based Omicron-specific Covid-19 booster vaccine.
Read more